Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
1m agoBRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe
1m agoPEPSI-COLA WORKERS IN GEORGIA JOIN TEAMSTERS
2m agoEdgeMode Appoints Capital Markets Specialist Simon Kiero-Watson to Board of Directors
2m agoSEGG Media Reports 1,400% Pro Forma Revenue Growth Following Acquisition of Veloce Media Group
4m agoKeyBank Expands Middle Market Banking Team in Southeast Michigan to Accelerate Regional Growth
Surenano Science Ltd logo

Surenano Science Ltd

About

Surenano Science Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 24 2026
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
Feb 23 2026
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
Dec 12 2025
SureNano Announces Stock Option Grant
Dec 10 2025
SureNano Announces Closing of $1,250,000 Private Placement
Nov 19 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Case study
How Surenano Science Ltd runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

SureNano Science Ltd. (SURE:CSE)
SureNano Science Ltd. (SURE:CSE)
Apr 21, 2022
SureNano Science Ltd. (SURE:CSE)
SureNano Science Ltd. (SURE:CSE)
Feb 18, 2022

Community Chat

Ask AI

6ix6ix